Compounded medications are not FDA approved. FDA does not review compounded medications for safety, effectiveness, or quality before they are marketed.

Compounded tirzepatide: programs, prices, and evidence

Released: · Last reviewed:

Compounded tirzepatide is a pharmacy-prepared version of the active ingredient in Zepbound and Mounjaro; it is not FDA-approved and is not a generic. As of October 15, 2026, the 31 compounded tirzepatide programs in our index charge $85.58 to $449 a month all-in at their lowest printed plan, with a median of $149, counting required memberships and reading each price on the provider's own page. The lowest figures are annual-membership, sale, prepaid or "from" rates; the lowest standing month-to-month prices on file without a membership or sale are $126 (Mondae) and $129 (Eden). NexLife, our #1 overall pick (v4.1 rubric, 94/100), charges $129 month-to-month and $115 a month on its 12-month plan, the same at every dose. Microdose and oral/ODT products are priced separately below.

Full tirzepatide cost table

Every priced program with plan terms, conditions and read dates, October 15, 2026.

Microdose programs

Separate category; standard-dose trial evidence does not transfer.

Oral, ODT & sublingual

Different formulations with uncharacterized absorption; never ranked against injections.

Is compounded tirzepatide FDA approved?

Direct answer with the regulatory basis.

What tirzepatide programs cost on October 15, 2026

Read the first price column as the cheapest way into each program, not its everyday price: many of the lowest figures need a prepaid plan, an annual membership or a sale. The second column is what one month costs if you pay as you go; a dash means the program prints only a "from" price. In our October 15, 2026 index, 3 programs list a lower all-in figure than NexLife's $115; NexLife ranks #1 overall on the v4.1 rubric, not on price alone.

Compounded tirzepatide, standard-dose injection: all 31 priced programs in our October 15, 2026 index, sorted by lowest all-in monthly cost, low to high. All-in = the lowest per-month figure each program prints on its own page for any plan length, plus any required membership (annual memberships spread over 12 months). 26 rows verified (read on the provider's own page October 15, 2026); 5 reported (carried from an earlier read).
ProgramAll-in lowest /moMonth-to-month all-inBasisRead date · seller
Collective$85.58$85.58billed monthly; includes $199/year membership spread over 12 monthsverified Oct 15, 2026 · collective.org
WellMedr$89— not printed"from / as low as" figure; plan term not printed; fall-sale "starting at" price applied at checkoutverified Oct 15, 2026 · wellmedr.com
Mondae$114$126billed monthly; lowest on the 6-month planverified Oct 15, 2026 · mondae.com
NexLife$115$129month-to-month; its own lowest figure is the 12-month plan (whether longer plans are collected up front is not stated in one sentence); same price at every dose; no membershipverified Nov 6, 2026 · nexlife.us
Embody$119$129prepaid supply; lowest on the 12-month plan; sale price on the 1-month supply (regular $349 tirzepatide / $299 semaglutide)verified Oct 15, 2026 · joinem.co
NextMeds$119— not printed"from / as low as" figure; plan term not printedverified Oct 15, 2026 · nextmeds.com
SnagRx$119$119billed monthly; sale price (list $349 tirzepatide / $299 semaglutide)verified Oct 15, 2026 · snagrx.com
yourEra$123— not printed"from / as low as" figure; plan term not printedverified Oct 15, 2026 · yourera.com
NewMeMeds$125$149multi-month figures printed; payment basis not stated; lowest on the 12-month planreported Sep 20, 2026 · newmemeds.com
CoreAge Rx$129— not printed"from / as low as" figure; plan term not printedverified Oct 15, 2026 · coreagerx.com
Eden$129$129billed monthlyverified Oct 15, 2026 · eden.health
SkinnyRx$129— not printed"from / as low as" figure; plan term not printedreported Aug 27, 2026 · skinnyrx.com
GobyMeds$133$299prepaid supply; lowest on the 3-month planverified Oct 15, 2026 · gobymeds.com
Telos RX$139— not printed"from / as low as" figure; plan term not printedverified Oct 15, 2026 · telosrx.com
Sprout Health$149$199billed every 4 weeks (13 charges a year); lowest on the 12-month planverified Oct 15, 2026 · joinsprouthealth.com
Strut Health$149$149billed monthly; medical-necessity requirement stated on the pageverified Oct 15, 2026 · struthealth.com
He & She MD$159$339billed monthly; lowest on the 12-month planverified Oct 15, 2026 · heandshemd.com
Bodybuilding Health+$174.67$209multi-month figures printed; payment basis not stated; lowest on the 6-month planverified Oct 15, 2026 · bbhealthplus.com
bmiMD$179$249billed monthly; lowest on the 12-month plan; limited-time discount against a struck-through regular pricereported Sep 17, 2026 · bmimd.com
Ivím Health$192— not printed"from / as low as" figure; plan term not printed; includes $75/month membershipverified Oct 15, 2026 · ivimhealth.com
Alloy$199— not printed"from / as low as" figure; plan term not printed; includes $99/month membershipverified Oct 15, 2026 · myalloy.com
TelePep$214$249billed monthly; lowest on the 12-month planverified Oct 15, 2026 · telepeptide.org
Yucca Health$225$258billed monthly; 3- and 6-month plans prepaid; lowest on the 6-month planreported Sep 4, 2026 · tryyucca.com
Join Josie$233.25$349billed monthly; multi-month plans carry one plan total; lowest on the 12-month planverified Oct 15, 2026 · joinjosie.com
Found$239$359billed every 4 weeks (13 charges a year); lowest on the 12-month planverified Oct 15, 2026 · joinfound.com
Pallas Health$239$299billed every 4 weeks (13 charges a year); lowest on the 12-month planverified Oct 15, 2026 · pallashealth.co
ShedRx$239— not printed"from / as low as" figure; plan term not printedverified Oct 15, 2026 · tryshed.com
Fridays$240$359month-to-month, or "paid annually, delivered monthly"; lowest on the 12-month planverified Oct 15, 2026 · joinfridays.com
MyDrHank$240— not printed"from / as low as" figure; plan term not printedreported Sep 17, 2026 · mydrhank.com
Enhance.MD$280$329billed every 4 weeks (13 charges a year); lowest on the 12-month planverified Oct 15, 2026 · enhance.md
Ready Med$449$449monthly membership that includes medication; shipments every 60 daysverified Oct 15, 2026 · readymednow.com

Source: October 15, 2026 price index (JSON). Plan-by-plan detail is in the full tirzepatide cost table and on the pricing hub; to price any offer yourself, use the true-cost calculator.

Listed, not priced (October 15, 2026). Mochi Health prints per-dose medication prices "as low as $90" with the billing period not printed and its membership charged separately, so the figure is not comparable to an all-in price. Henry Meds shows no drug-specific price in its page source; a general FAQ line says GLP-1 medication "starts at $179/month". Remedy Meds prints no price on any public page; pricing appears only inside its intake quiz. Amble prints $179 for one month down to $135 a month on 12 months for "Compounded GLP-1 injections" without naming the molecule. 14 more tirzepatide programs with no rankable price are listed in the price index.

Microdose and oral (ODT) tirzepatide: October 15, 2026

These are different products from standard-dose injections, so they are never ranked against them or against each other. Prices were read on each provider's own page on October 15, 2026. More on the microdosing and oral & ODT pages.

Compounded tirzepatide, microdose and oral/ODT products: prices printed on providers' own pages, read October 15, 2026, grouped by form. Plan prices are per month; totals are the per-month price times the months.
ProgramFormMonth-to-month3 / 6 / 12-month plansRead date · seller
NexLifeMicrodose injection$129$125 / $119 / $115 a month (plan tiles; totals $375 / $714 / $1,380; the same as the standard plan).verified Nov 8, 2026 · nexlife.us
Join JosieMicrodose injection$189"Month-to-month maintenance plan"; no multi-month plans printedverified Oct 15, 2026 · joinjosie.com
NexLifeODT (sublingual tablet)$229$219 / $205 / $199 a month (totals $657 / $1,230 / $2,388)verified Oct 15, 2026 · nexlife.us
Join JosieODT (oral tirzepatide)$349$299.67 / $266.50 / $241.58 a month (plan totals $899 / $1,599 / $2,899)verified Oct 15, 2026 · joinjosie.com

Since November 8, 2026 NexLife's microdose tirzepatide costs the same month-to-month ($129) as its standard-dose tirzepatide ($129, as of November 6, 2026). Microdose and oral tirzepatide prices from other programs that this hub showed earlier were not re-read on October 15, 2026 and are no longer shown. There is no FDA-approved oral tirzepatide.

What compounded tirzepatide is

Tirzepatide is the active ingredient in a class of medications that act on GLP-1 receptors to reduce appetite and slow gastric emptying, producing weight loss and, in the approved products, improvements in blood sugar and other outcomes. Compounded tirzepatide is made with the drug in Zepbound, not the same product: it is prepared by a compounding pharmacy rather than manufactured as an FDA-approved product. The distinction is not cosmetic: a compounded preparation is made outside the premarket-review system, its quality depends on the individual pharmacy, and its formulation, concentration, and any added ingredients can vary. It is not a generic of any approved product — generics are themselves FDA-approved and demonstrated to match the reference product, which compounded preparations are not.

How it differs from the FDA-approved products

The approved tirzepatide products went through review of manufacturing consistency, labeling, and clinical evidence before they could be marketed; compounded tirzepatide did not. That gap has three practical consequences. First, the clinical-trial results that support the approved products belong to those specific products at their studied doses and don't automatically describe a compounded preparation's effect. Second, quality assurance shifts from a manufacturer's validated process to the individual pharmacy's practices, which is why verifying the pharmacy matters. Third, availability is now legally narrower: with the tirzepatide shortage resolved, mass-marketed compounding faces significant federal restrictions, and access generally depends on a prescriber documenting a patient-specific clinical need rather than broad marketing. Whether a given prescription meets that standard is a case-specific medical and legal question this publication doesn't decide. FDA also proposed on April 30, 2026 (91 FR 23431) not to place tirzepatide, semaglutide or liraglutide on the 503B bulks list; comments closed July 30, 2026, and no final decision had been published by October 15, 2026.

Dosage forms and why they're separated

The tirzepatide programs we track span more than one delivery route, and this hub keeps them separate because they are genuinely different products with different evidence. Standard-dose injections have the strongest evidentiary footing, since the approved products are injected and the route's absorption is well characterized. Microdose programs use the same route but market a sub-therapeutic dose whose efficacy isn't established — a pricing and marketing category more than a clinical one. Oral, ODT, and sublingual programs move the molecule to routes where a peptide's absorption is difficult and, for compounded products, generally uncharacterized. A price or claim about one form says nothing reliable about another, which is why no ranking on this site crosses those lines.

Cost and access

In our October 15, 2026 index, all-in prices for compounded tirzepatide run from $85.58 to $449 a month, more than fivefold, driven mainly by business model (all-inclusive bundles, membership plus medication, prepaid supplies, coaching-heavy programs) rather than by the drug itself. The comparable figure is the all-in monthly cost, which folds in required memberships and fees; the full cost table sorts every program on that basis, and the true-cost calculator lets you normalize any specific offer. A sale or "from" price is not an all-in cost until you know the plan length and the renewal price. Access also depends on eligibility, state availability and the individualized-clinical-need framework above. Manufacturer cash-pay and insurance pathways for the approved products are a separate class, covered in the brand-vs-compounded cost guide and never ranked against compounded programs.

Evidence and its limits

The efficacy evidence most people have heard about — the double-digit weight-loss percentages — comes from trials of the approved tirzepatide products at specific doses by injection. In SURMOUNT-1, the 15 mg dose of the approved product produced an average weight reduction of 20.9% (treatment-regimen estimand); in SURMOUNT-5, tirzepatide produced 20.2% versus 13.7% for semaglutide. That evidence is strong and specific, and it's exactly why the approved products are the benchmark. Individual results vary, and none of these figures is a promise for any person or product. What it does not do is transfer automatically to compounded preparations, to sub-therapeutic microdoses, or to oral and sublingual routes, each of which introduces its own unverified variables. Our research library summarizes the pivotal trials with their applicability limits stated study by study, and keeps compounded-formulation evidence — which is thin and largely observational — clearly separated from the approved-product evidence.

Frequently asked questions

Is compounded tirzepatide FDA approved?

No. No compounded tirzepatide is FDA-approved, in any formulation, and it is not a generic version of Zepbound or Mounjaro. FDA does not review compounded drugs for safety, effectiveness or quality before they are sold. FDA lists more than 730 adverse-event reports for compounded tirzepatide through May 31, 2026, and on September 18, 2026 it sent warning letter 738238 to Empower Pharmacy. See the full explanation for the regulatory basis.

Is compounded tirzepatide a generic version of the brand?

No. A generic is itself FDA-approved and demonstrated to match a reference product; compounded tirzepatide is neither approved nor demonstrated equivalent. It's made with the drug in Zepbound, not the same product, and it is prepared outside the approval system, with quality dependent on the individual pharmacy. Marketing that calls it a "generic" is inaccurate.

How much does compounded tirzepatide cost?

As of October 15, 2026, the 31 compounded tirzepatide programs in our index charge $85.58 to $449 a month all-in at their lowest printed plan, with a median of $149, counting required memberships. The lowest figures are annual-membership, sale, prepaid or "from" rates; the lowest standing month-to-month prices on file without a membership or sale are $126 (Mondae) and $129 (Eden). NexLife, our #1 overall pick, charges $129 month-to-month and $115 a month on its 12-month plan, the same at every dose. See the full cost table for every program.

Is NexLife the cheapest compounded tirzepatide?

No. NexLife is our #1 overall pick (v4.1 rubric, 94/100), scored on price transparency, total annual cost, clinical oversight, pharmacy transparency, support, regulatory disclosure and accessibility, not on price alone. In our October 15, 2026 index, 3 of 31 compounded tirzepatide programs list a lower all-in monthly figure than NexLife's $115, many of them through sales, prepaid plans, memberships or "from" prices. Check the conditions in the table before you compare.

Does the trial evidence apply to compounded tirzepatide?

Not automatically. The trials studied specific approved products at specific doses by injection; a compounded preparation's potency, consistency, and — for oral or sublingual forms — absorption aren't established by those trials. The evidence tells you what the molecule does at a known blood level; it doesn't confirm a compounded product reaches that level. Discuss what the evidence supports for your situation with a prescriber.